CARsgen Therapeutics Holdings Limited Share Price
Equities
2171
KYG1996C1006
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.6 HKD | +2.75% | +24.44% | -13.85% |
12/04 | Carsgen Therapeutics To Give Cancer Drug Oral Presentation at ASCO 2024 | MT |
26/03 | CARsgen Therapeutics Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 330M 45.68M 357M 3.81B | Sales 2025 * | 895M 124M 969M 10.33B | Capitalization | 2.98B 412M 3.23B 34.39B |
---|---|---|---|---|---|
Net income 2024 * | -680M -94.03M -736M -7.84B | Net income 2025 * | -708M -97.9M -766M -8.17B | EV / Sales 2024 * | 6.07 x |
Net cash position 2024 * | 976M 135M 1.06B 11.26B | Net cash position 2025 * | 990M 137M 1.07B 11.42B | EV / Sales 2025 * | 2.22 x |
P/E ratio 2024 * |
-4.3
x | P/E ratio 2025 * |
-4.13
x | Employees | 516 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.71% |
1 day | +2.75% | ||
1 week | +24.44% | ||
Current month | -7.28% | ||
1 month | -7.28% | ||
3 months | +21.21% | ||
6 months | -44.00% | ||
Current year | -13.85% |
Managers | Title | Age | Since |
---|---|---|---|
Hua Mao Wang
FOU | Founder | 48 | 09/18/09 |
Zong Hai Li
CEO | Chief Executive Officer | 51 | 09/18/09 |
Lan Xie
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zong Hai Li
CEO | Chief Executive Officer | 51 | 09/18/09 |
Hua Mao Wang
FOU | Founder | 48 | 09/18/09 |
Xiang Ke Zhao
BRD | Director/Board Member | 38 | 04/23/04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.19% | 4 M€ | -27.92% | ||
0.03% | 2 M€ | -.--% | ||
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 5.6 | +2.75% | 1 512 300 |
26/24/26 | 5.45 | +2.25% | 1,176,500 |
25/24/25 | 5.33 | +5.54% | 2,007,500 |
24/24/24 | 5.05 | +7.68% | 1,132,500 |
23/24/23 | 4.69 | +3.76% | 1,097,000 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 01:38 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.85% | 401M | |
-2.57% | 103B | |
+1.58% | 95.28B | |
+1.46% | 22.15B | |
-15.53% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.90% | 16.05B | |
+5.38% | 13.68B | |
+33.51% | 12.17B |
- Stock Market
- Equities
- 2171 Stock